Malignancy in Cases with Suspected Mature Cystic Teratoma in The Preoperative and Intraoperative Evaluations

dc.contributor.authorCoban, Gonca
dc.contributor.authorYalcinkaya, Cem
dc.contributor.authorKalayci, Hakan
dc.contributor.authorBolat, Filiz Aka
dc.contributor.authorCelik, Husnu
dc.contributor.orcIDhttps://orcid.org/0000-0002-3285-5519en_US
dc.contributor.orcIDhttps://orcid.org/0000-0003-2031-7374en_US
dc.contributor.researcherIDAAI-9974-2021en_US
dc.contributor.researcherIDHJZ-1654-2023en_US
dc.contributor.researcherIDAAL-1923-2021en_US
dc.date.accessioned2023-05-24T08:01:10Z
dc.date.available2023-05-24T08:01:10Z
dc.date.issued2018
dc.description.abstractObjective: To report cases who were suspected to have mature cystic teratoma in the preoperative and intraoperative periods, but were found to have malignancy together with mature cystic teratoma in the final histopathological examination. Materials and Methods: The medical records of 148 cases were retrieved. The records were used to review the sociodemographic properties, histopathology, intraoperative tumor size, the surgical procedure, adjuvant therapy, and follow-up of the patients who were suspected to have mature cystic teratoma in the preoperative and intraoperative periods, but were found to have malignancy together with mature cystic teratoma in the frozen or final histopathological examination. Results: Of the patients, 8.2% were found to have malignancy arising in mature cystic teratoma. The median age of the patients was 32- (min: 15, max: 66) years-old and the tumor size was 12.1 (min: 4, max: 25) cm. Six patients were established to have an immature teratoma, three had a carcinoid tumor, one had a primitive neuro-extrodermal tumor (PNET), one had serous borderline tumor, and one had a borderline mucinous tumor. Conclusion: Although a mature cystic teratoma is benign, since it may involve different degrees of malignancy, intraoperative attitudes and procedures should follow the rules that apply to the management of a complicated adnexal mass and the possibility of a malignant transformation should be in kept in mind when informing the patient in the preoperative period.en_US
dc.identifier.endpage557en_US
dc.identifier.issn0392-2936en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85052092474en_US
dc.identifier.startpage554en_US
dc.identifier.urihttp://hdl.handle.net/11727/9134
dc.identifier.volume39en_US
dc.identifier.wos000444419100007en_US
dc.language.isoengen_US
dc.relation.isversionof10.12892/ejgo4163.2018en_US
dc.relation.journalEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMature cystic teratomaen_US
dc.subjectMalignancyen_US
dc.subjectImmature teratomaen_US
dc.titleMalignancy in Cases with Suspected Mature Cystic Teratoma in The Preoperative and Intraoperative Evaluationsen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: